
Quality of Life on Arterial Hypertension: Validity of Known Groups of MINICHAL
2015; Sociedade Brasileira de Cardiologia (SBC); Linguagem: Inglês
10.5935/abc.20150009
ISSN1678-4170
AutoresAna Lúcia Soares Soutello, Roberta Cunha Matheus Rodrigues, Fernanda Freire Jannuzzi, Thaís Moreira São‐João, Gabriela Giordano Martini, Wilson Nadruz, Maria Cecília Bueno Jayme Gallani,
Tópico(s)Global Health Care Issues
ResumoBackground: In the care of hypertension, it is important that health professionals possess available tools that allow evaluating the impairment of the health-related quality of life, according to the severity of hypertension and the risk for cardiovascular events.Among the instruments developed for the assessment of health-related quality of life, there is the Mini-Cuestionario of Calidad de Vida en la Hipertensión Arterial (MINICHAL) recently adapted to the Brazilian culture.Objective: To estimate the validity of known groups of the Brazilian version of the MINICHAL regarding the classification of risk for cardiovascular events, symptoms, severity of dyspnea and target-organ damage.Methods: Data of 200 hypertensive outpatients concerning sociodemographic and clinical information and health-related quality of life were gathered by consulting the medical charts and the application of the Brazilian version of MINICHAL.The Mann-Whitney test was used to compare health-related quality of life in relation to symptoms and target-organ damage.The Kruskal-Wallis test and ANOVA with ranks transformation were used to compare health-related quality of life in relation to the classification of risk for cardiovascular events and intensity of dyspnea, respectively.Results: The MINICHAL was able to discriminate health-related quality of life in relation to symptoms and kidney damage, but did not discriminate health-related quality of life in relation to the classification of risk for cardiovascular events. Conclusion:The Brazilian version of the MINICHAL is a questionnaire capable of discriminating differences on the health-related quality of life regarding dyspnea, chest pain, palpitation, lipothymy, cephalea and renal damage.
Referência(s)